SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-001215
Filing Date
2011-01-07
Accepted
2011-01-07 07:14:51
Documents
8
Period of Report
2011-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a58242e8vk.htm 8-K 17202
2 EX-4.1 a58242exv4w1.htm EX-4.1 116607
3 EX-4.2 a58242exv4w2.htm EX-4.2 66373
4 EX-5.1 a58242exv5w1.htm EX-5.1 11064
5 EX-10.1 a58242exv10w1.htm EX-10.1 93702
6 EX-99.1 a58242exv99w1.htm EX-99.1 8908
7 GRAPHIC a58242a5824201.gif GRAPHIC 5562
8 GRAPHIC a58242a5824202.gif GRAPHIC 4651
  Complete submission text file 0000950123-11-001215.txt   329884
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
ADVENTRX PHARMACEUTICALS INC (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 11515655
SIC: 2834 Pharmaceutical Preparations